Review
Published on 27 May 2020
Peroxisome Proliferator-Activated Receptors: Experimental Targeting for the Treatment of Inflammatory Bowel Diseases
in Gastrointestinal and Hepatic Pharmacology
- 29,028 views
- 114 citations
Review
Published on 27 May 2020
in Gastrointestinal and Hepatic Pharmacology
Original Research
Published on 20 May 2020
in Gastrointestinal and Hepatic Pharmacology
Original Research
Published on 14 May 2020
in Gastrointestinal and Hepatic Pharmacology
Original Research
Published on 08 May 2020
in Gastrointestinal and Hepatic Pharmacology
Original Research
Published on 06 May 2020
in Gastrointestinal and Hepatic Pharmacology
Correction
Published on 05 May 2020
in Gastrointestinal and Hepatic Pharmacology
Review
Published on 30 Apr 2020
in Gastrointestinal and Hepatic Pharmacology
Original Research
Published on 29 Apr 2020
in Gastrointestinal and Hepatic Pharmacology
Original Research
Published on 24 Apr 2020
in Gastrointestinal and Hepatic Pharmacology
Review
Published on 22 Apr 2020
in Gastrointestinal and Hepatic Pharmacology
Editorial
Published on 21 Apr 2020
in Gastrointestinal and Hepatic Pharmacology
Original Research
Published on 21 Apr 2020
in Gastrointestinal and Hepatic Pharmacology
Original Research
Published on 17 Apr 2020
in Gastrointestinal and Hepatic Pharmacology
Original Research
Published on 08 Apr 2020
in Gastrointestinal and Hepatic Pharmacology
Original Research
Published on 07 Apr 2020
in Gastrointestinal and Hepatic Pharmacology
Original Research
Published on 03 Apr 2020
in Gastrointestinal and Hepatic Pharmacology